Artículo
A Comprehensive Workflow for Plasma Proteomics by Mass Spectrometry: A Strategy for Biomarker Discovery in Systemic Human Diseases.
Research record from J Vis Exp, 2026-03-13. PMID 41911173.
Loading
Loading
Busque productos, empresas, pruebas y guías: pase de la consulta a la solicitud de cotización en un solo lugar.
Artículo
Research record from J Vis Exp, 2026-03-13. PMID 41911173.
Artículo
Research record from Access Microbiol, 2026-09-02. PMID 42688888.
Artículo
Research record from J Vis Exp, 2026-10-13. PMID 42872719.
Artículo
Research record from Acta Parasitol, 2026-03-13. PMID 41824130.
Artículo
Research record from Clin Chem Lab Med, 2026-08-12. PMID 42578267.
Artículo
Research record from J Mass Spectrom, 2026-08-01. PMID 42464011.
Artículo
Research record from Mikrochim Acta, 2026-04-10. PMID 41961135.
Artículo
Research record from Anal Sci Adv, 2026-04-06. PMID 41947975.
Artículo
Research record from Front Immunol, 2026-05-08. PMID 42183289.
Artículo
Research record from J Sep Sci, 2026-10-01. PMID 42905307.
Pruebas
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Abbott Alinity i system. The persistence of immunoglobulin class G (IgG) antibodies may identify people who have been infected in the past, recovered from the illness, and possibly developed immunity.
Pruebas
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum and plasma on the Abbott Alinity i system. The presence of IgM antibodies may be associated with recent infection or may assist with the evaluation of disease course.